Risk of Reoperation Up With Perianal Lesions in Crohn's

This article originally appeared here.
Share this content:
Risk of Reoperation Up With Perianal Lesions in Crohn's
Risk of Reoperation Up With Perianal Lesions in Crohn's

MONDAY, Feb. 15, 2016 (HealthDay News) -- For patients with Crohn's disease, the risk of reoperation is increased for those with perianal lesions, according to a study published online Feb. 5 in the Journal of Gastroenterology and Hepatology.

Yoo Min Han, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined the long-term prognosis of perianal Crohn's disease. Patients who had undergone surgical bowel resection were classified according to the presence of perianal lesions (45 patients with perianal disease and 87 patients without perianal disease). The authors examined occurrences of abdominal and/or perianal reoperation and readmission attributed to disease flare-up.

The researchers found that, compared with patients without perianal disease, patients with perianal disease were younger (P = 0.015) and had been diagnosed at a younger age (P = 0.005). More extra-intestinal manifestation was seen for patients with versus those without perianal disease (P = 0.008). During the follow-up period, 44.8 percent of patients required reoperation. The risk of reoperation was independently increased with the presence of perianal disease (hazard ratio, 3.112). The risk of abdominal reoperation was also increased for patients with perianal disease (hazard ratio, 1.978).

"Considering these findings, physicians should consider aggressive and early top down therapy for patients with perianal Crohn's disease," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »